Indication
Multiple Organ Dysfunction Syndrome
2 clinical trials
2 products
Clinical trial
Early Intervention With Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome (TMA/aHUS)-Associated Multiple Organ Dysfunction Syndrome (MODS) in Hematopoietic Stem Cell Transplant (HCT) RecipientsStatus: Completed, Estimated PCD: 2022-04-04
Product
EculizumabClinical trial
Pediatric Immune Response to Multi-Organ DysfunctionStatus: Completed, Estimated PCD: 2024-04-16
Product
Blood test